MedTrace Logo

VASCADE ANTEGRADE-PVD Post-Market Registry

NCT02948257 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2020-01-18

Study results available
· View outcomes & findings →

Summary

The objective of the registry is to collect procedural outcomes data when the Cardiva VASCADE Vascular Closure System (VCS) is used to seal femoral arterial access sites at the completion of ipsilateral peripheral interventional procedures performed through 5-7F introducer sheaths via an antegrade approach.

Conditions

  • Surgical Wound

Interventions

DEVICE

Cardiva Medical VASCADE VCS

At the end of peripheral endovascular interventional procedures performed via an antegrade femoral arterial approach, the femoral arterial access site is closed with the VASCADE VCS to achieve arterial hemostasis.

Sponsors & Collaborators

  • Cardiva Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Mehdi Shishehbor, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-19
Primary Completion
2017-09-18
Completion
2017-09-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02948257 on ClinicalTrials.gov